Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.41) by 12.2 percent. This is unchanged from the same period last year. The company reported quarterly sales of $22.54 million which beat the analyst consensus estimate of $22.03 million by 2.29 percent. This is a 19.54 percent increase over sales of $18.85 million the same period last year.